Abstract
Noncanonical secondary structures of DNA have been well characterized in vitro for their catalytic and sensory functions, as well as in vivo for their regulatory functions in the genome. However, their presence and functional significance in the extracellular DNA (eDNA), particularly within biofilms and neutrophil extracellular traps (NETs), have only recently begun to be appreciated and have yet to be fully understood. Emerging studies have identified these atypical DNA conformations as integral components that contribute to the structural stability of biofilms and antimicrobial activity of NETs. In this personal view, we advocate for a comprehensive investigation of these unconventional DNA structures within extracellular contexts, where their distinct physiochemical properties are exposed to dynamic and unpredictable microenvironments, with the potential to profoundly influence microbial behaviour, immune responses, and host–pathogen interactions. Considering the broad spectrum of diseases associated with biofilm and NETs, targeting noncanonical eDNA structures may offer novel therapeutic avenues and shed light on mechanisms of immune tolerance and dysregulation.
Graphical Abstract
Graphical Abstract.
Introduction
Noncanonical secondary structures of DNA, deviating from the classical B-DNA double helix, have been found in the genomes of thousands of organisms across the tree of life [1–3]. Formation of structures such as G-quadruplexes (G4), Z-DNA, Holliday junctions (HJ), cruciforms, triplexes, hairpins, and i-motifs can be strongly influenced by specific sequence motifs that are widely distributed throughout the genome [4]. For example, G4 arise from guanine-rich sequences where four guanines form Hoogsteen hydrogen bonds, resulting in planar tetrads [5]. In contrast, Z-DNA is in equilibrium with B-DNA, and its formation is not strictly sequence specific and, in principle, can occur at any sequence under sufficient negative supercoiling. Nevertheless, alternating purine-pyrimidine/GC-rich tracts (e.g. poly(dG-dC)) substantially lower the energetic threshold for the B-to-Z transition, often making them ideal genomic sites for Z-DNA formation [6]. Beyond primary sequences, formation of these dynamic alternative conformations also depends on various cellular and environmental factors, such as superhelical stress, chromatin conformation [7], oxidative stress, ligands, ions, and pH [8–10]. Intracellularly, these structures on nuclear DNA have been implicated in the regulation of biological processes such as replication, transcription, recombination, maintaining genetic stability, DNA damage and repair [4], and protecting cells from hemin toxicity [11]. However, little is known about their existence or potential roles in extracellular DNA, particularly the functionalized bioactive free eDNA found in biofilms and neutrophil extracellular traps (NETs)—two biologically distinct yet pathologically convergent systems. Extracellular DNA (eDNA) can arise not only from passive release (e.g. cell lysis or apoptosis) but also from programmed regulated processes such as NETosis, autolysis, or phage-mediated lysis, where DNA release appears to occur in response to stress, infection, or disease [12]. Given the conditions outside a cell differ drastically from those within, while the noncanonical secondary structures primarily regulate gene expression intracellularly, their properties and functions are likely distinct and more diverse in the complex extracellular environments subject to unpredictable perturbations.
Biofilms and NETs represent fascinating biological systems both rich in eDNA [13, 14]; however, the noncanonical structures of eDNA are still underexplored in these contexts. In addition to promoting structural stability in both systems [15–17], these alternative forms may also contribute to immune evasion in biofilm and antimicrobial defence in NETs [16, 17] (Fig. 1A). Moreover, these conformations may have unique immunostimulatory potential, acting as potent structural pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs), triggering and amplifying immune responses from pattern-recognition receptors (PRRs) with implications in prolonged inflammation and autoimmune activation. Given the disparate biological settings from which eDNA arises in biofilms or NETs, as well as their dynamic interplay with each other as part of host–pathogen interaction [16], these systems offer a unique opportunity to draw comparisons and gain novel insights into the roles of noncanonical eDNA structures in disease mechanisms, microbial behaviours, and immune responses. In this perspective, we propose that unique secondary structures are integral to eDNA and that studying these less understood systems would uncover new biological roles of eDNA and highlight their potential as therapeutic targets. We will focus on G4 and Z-DNA due to the greater body of evidence supporting their relevance in these contexts compared to other structures.
Figure 1.
Conceptual model of bioactive eDNA structures and their role in host–pathogen interactions within the context of NETs and bacterial biofilms. This illustration depicts key structural and functional features of eDNA released during NETosis and its interaction with a component of a schematic aggregate bacterial biofilm. NETs entrap bacteria and contain structurally diverse DNA elements, including Z-DNA stabilized by bacterial DNABII proteins, G4, and mitochondrial DNA (mtDNA). Host-derived Z-DNA-binding protein 1 (ZBP1) binds Z-DNA motifs released in both free circular or vesicle-associated mtDNA, stabilizing the left-handed conformation. Within bacterial biofilms, structural integrity is reinforced by both G4 and Z-DNA stabilized through interactions of DNABII proteins at Holliday junctions. (A) NETs eDNA: highlights the bactericidal potential of G4/hemin complexes, which exhibit peroxidase activity by converting H₂O₂ into hydroxyl radicals (•OH), leading to bacterial killing. In contrast, unbound hemin alone does not induce bactericidal effects. Nuclear and mitochondrial DNA released during NETosis are subject to conditions shifting the equilibrium towards the formation of Z-DNA in DNase rich blood and have to cast a wide NET to trap pathogens. NETs can adopt Z-form in the presence of bacterial DNABII, and ZBP1 binds to mtDNA. (B) Nuclease resistance: illustrates that both G4 and Z-DNA, anchored by Holliday junctions in biofilm, and NET eDNA resist degradation by nucleases such as DNase I and DNase1L3, whereas canonical B-form DNA is susceptible to enzymatic digestion. (C) G4/hemin-mediated EET: Presents a conceptual model for G4/hemin-mediated extracellular electron transfer (EET) in biofilms, suggesting that noncanonical eDNA structures participate in redox reactions within the extracellular matrix. Together, these panels propose that noncanonical eDNA structures form a structural and functional interface between host and pathogens, contributing to antimicrobial defence, immune modulation, and biofilm resilience. Created in BioRender. Demir, T. D. (2025) https://BioRender.com/n2fzaih.
Structural basis of noncanonical secondary DNA structures
G4s arise predominantly from guanine-rich sequences, typically following the consensus motif G≥3N1–7G≥3N1–7G≥3N1–7G≥3 [18], in which guanines form planar tetrads through Hoogsteen hydrogen bonding and stack into higher-order structures. They can adopt intramolecular (within a single strand) or intermolecular (between two or more strands) configurations and display diverse topologies—parallel, antiparallel, or hybrid—depending on loop arrangement, strand orientation [19], and syn/anti glycosidic conformations of guanines [20]. A simple rule links strand orientation with glycosidic conformation: guanines aligned in the same strand direction adopt the same glycosidic conformation, whereas guanines in opposite orientations adopt opposite conformations [20]. This structural diversity allows G4s to adapt dynamically to environmental conditions. Their stability is strongly dependent on cations, with potassium conferring the greatest stabilization, sodium supporting antiparallel folding, and divalent ions such as magnesium and calcium modulating stability under physiological conditions [3, 19]. Given that inflamed tissues often exhibit local sodium accumulation and altered ionic microenvironments, and that biofilm growth is supported by increased salt concentrations, these ionic dependencies may critically shape the stability and persistence of extracellular G4s [21–23]. Beyond ionic regulation, naturally occurring small molecules can also act as G4 ligands. Hemin, a heme-derived porphyrin released during hemoprotein turnover and inflammation, binds and stabilizes G4s and forms catalytically active G4/hemin DNAzymes [11, 17, 24]. Likewise, polyamines such as spermine and spermidine—abundant in mammalian cells—interact electrostatically with DNA and contribute to G4 stabilization [25–27]. Together, these endogenous ligands suggest that the cellular milieu provides not only ions but also bioactive metabolites that can modulate G4 conformation and function. In addition to these physiological ligands, a wide spectrum of artificial small molecules, including porphyrin derivatives, acridines, and quinolines, have been designed to selectively stabilize or destabilize G4s, expanding their potential as therapeutic targets [28].
Z-DNA, on the other hand, represents a left-handed helical conformation of the double helix, characterized by a zig-zag phosphate backbone and alternating syn/anti glycosidic conformations [29] that is formed without sequence specificity but with a higher propensity towards alternating purine–pyrimidine motifs [30]. Formation is strongly promoted by base modifications, the presence of Z-alpha domain-containing proteins, negative supercoiling during transcription, mechanical strain, and high salt or polycationic environments [31, 32]. A wide range of ligands, like natural polyamines such as spermine and spermidine, can stabilize Z-DNA like G4 [33]. Unlike G4s, which rely primarily on cation-mediated Hoogsteen stabilization, Z-DNA formation depends on torsional stress and electrostatic neutralization, highlighting a mechanistic contrast between these noncanonical structures [32, 34].
pH is likely a potential regulator of the dynamic equilibrium between the B and noncanonical structures of the DNA. Low pH can favour DNA towards non-B conformations or favour a switch between two non-B conformations. Hettiarachchi et al. reported that while DNA retains its B-form at neutral pH, it shifts towards the Z-form under acidic conditions (pH 3–5), driven by electrostatic attraction between the phosphate backbone and positively charged surfaces [35]. Protonation of adenine and cytosine further alters hydrogen-bonding patterns, enhancing flexibility and promoting Z-DNA stabilization. In addition, it was observed that an oligonucleotide that formed an anti-parallel G4 under acidic pH conditions switched to a double-stranded structure under neutral or alkaline pH [36]. Together, these findings suggest that acidic extracellular niches, common in biofilms and inflamed tissues, may tip the dynamic equilibrium towards the formation and stabilization of more noncanonical DNA conformations, thereby influencing the structural dynamics of extracellular DNA. Beyond these factors, extracellular and membrane-bound lipids may also modulate DNA topology. For example, high concentrations of phosphatidylethanolamine can destabilize B-DNA, whereas lower levels stabilize duplexes, suggesting a concentration-dependent influence on nucleic acid structure [37]. In vitro lipid modifications have likewise been shown to alter folding and stability of synthetic G4s [38]. Therefore, lipid–DNA interactions arising during membrane disruption or vesicle release may transiently alter local hydrophobicity and thereby modulate the stability or conformation of eDNA, an underexplored dimension of eDNA regulation. Consistent with this notion, G4 structures were observed in close proximity to the cell surface in Staphylococcus epidermidis biofilms, raising the possibility that membrane-associated components could influence eDNA conformations [39].
Noncanonical secondary structures in biofilm eDNA
Biofilms are structured microbial communities embedded within an extracellular polymeric substance (EPS), a matrix composed of carbohydrates, lipids, proteins, and eDNA, with considerable compositional heterogeneity across species [12, 40]. Notably, eDNA is one of the few matrix components conserved across genera, emphasizing its foundational role in biofilm architecture. Although eDNA typically constitutes up to 50% of the biofilm matrix by mass depending on the species [41, 42], it plays a disproportionately critical role in biofilm architecture and function. DNA has been recognized as a component of bacterial EPS since the 1950s [43]. In 2002, eDNA was demonstrated to be an essential component of Pseudomonas aeruginosa biofilms [13], and since then, it has been recognized as a ubiquitous component of biofilms of diverse bacterial species and fungi [12, 44, 45]. The source of eDNA in biofilms is multifactorial. Mechanisms include active secretion of genomic DNA, often mediated by type IV and VI secretion systems; membrane vesicles and virulence factors [46] in response to quorum sensing signals [40, 47, 48]; passive release via autolysis or allolysis (fratricide) [49], antibiotic treatment [50], and the effect of monovalent cations [51]; competitive killing through toxin release, such as colicins or T6SS effectors, which lyse weaker competitors within the community [52, 53]; phage-induced lysis, including stress-activated prophage-mediated lysis, an efficient programmed route for eDNA increasing through sister-cell killing [54–57]; and incorporation of host-derived DNA such as NETs [58, 59]. Beyond its structural role as a scaffold facilitating cell attachment and aggregation, eDNA enhances biofilm mechanical integrity by forming higher-order conformations and its resilience by resisting degradation [15, 16, 60] (Fig. 1B). For instance, Aspergillus fumigatus biofilms rely on eDNA release as an antifungal resistance mechanism, particularly in mature communities [45]. eDNA also contributes to functional compartmentalization within the matrix, forming charged microenvironments [61] and amyloid fiber-modulated layers that modulate diffusion and signalling [62]. Functionally, eDNA acts as a reservoir for horizontal gene transfer, promoting genetic diversity and DNA damage repair [63]. It also participates in EET pathways, playing a role in energy metabolism, thereby facilitating metabolic health for bacteria in the anoxic environments of the biofilm [64]. Additionally, eDNA serves as a source of carbon, nitrogen, and phosphate [65], supporting biofilm’s survival in hostile environments [22]. Emerging evidence suggests prophage-mediated replication and extracellular synthesis of DNA within the biofilm, thereby contributing to its architecture and further highlighting the potential for other molecular processes within the extracellular milieu biofilm [66].
Recent studies have identified noncanonical secondary structures within the eDNA of biofilms, functionally distinct from their intracellular counterparts. G4s were first detected in P. aeruginosa biofilms under both static and dynamic conditions [15] and have since been observed in diverse species [39]. These structures could enhance the physical robustness of biofilms by assembling into higher-order networks, increasing mechanical strength, viscoelasticity, and resistance of the scaffold to nuclease digestion, particularly DNase I [15, 39], and enhancing resilience against host immunity. Moreover, once formed, G4s are thermodynamically and chemically stable, especially under physiological ionic concentrations [8], which could enable their maintenance under fluctuating environmental conditions such as oxidative stress, pH fluctuation, and variable ionic compositions.
In addition to structural roles, extracellular G4s may also function as dynamic environmental sensors that modulate biofilm physiology in response to external cues. G4 structures are known to adopt diverse intra- and intermolecular configurations and topologies—parallel, antiparallel, and hybrid forms—in reaction to local ionic strength, pH, oxidative stress, and presence of small molecules or ligands [5, 9, 19]. These structural polymorphisms, with different inherent properties, could allow G4s to respond rapidly and reversibly to environmental perturbations. G4s can bind a wide variety of small molecules, with over 4563 known ligands [67]. One such ligand is hemin, an iron-containing porphyrin derived from heme, which can accumulate in host-associated biofilms due to inflammation [11], where increased release of NETs releases endogenous hemin. Hemin-bound G4s (G4/hemin) can form catalytic, peroxidase-like DNAzymes [24]. The G4/hemin complex can function as a redox-active sensor capable of detecting external stimuli and catalysing the production of reactive oxygen species (ROS), which in turn activate various oxidative stress response pathways [68, 69]. In the biofilm milieu, this system may help promote adaptation to oxidative stress by modulating redox signalling cascades and facilitating detoxification of ROS, thereby contributing to biofilm resilience. Interestingly, however, the DNAzyme activity in biofilms seems dominated by parallel G4s with representation from RNA G4s [39]. Similarly, interaction of G4s with redox-active metabolites such as phenazine may play a role in sensing and maintaining redox balance under anoxic conditions [64, 70, 71]. In addition to sensing, G4s may also function as electrical signal conductors, facilitating EET (Fig. 1C). G4 is more electroactive than B-DNA and can transmit charges over long distances [72, 73]. In S. epidermidis, G4/hemin was observed to mediate EET under anoxic conditions [71]. Recent work has further suggested that noncanonical nucleic acid structures, including RNA G4s, may also contribute to EET processes in microbial systems, highlighting a broader role for nucleic acid conformations in biofilm redox biology [71, 74]. While direct evidence remains limited, G4–ligand complexes could enable biofilms to conduct electrical signals, potentially supporting metabolic cooperation and redox balance within a stratified biofilm environment.
Z-DNA, another noncanonical DNA conformation, has also been detected in microbial eDNA directly from fabric and from that of mature biofilms (grown for >24 h in vitro) [16, 39, 75, 76]. As described previously, Z-DNA formation is typically induced by negative supercoiling during transcription or by mechanical strain and occurs preferentially at specific repeat sequences that are widely distributed through eukaryotic and prokaryotic genomes. While Z-DNA can form at any sequence of B-DNA, poly(dG-dC) tracts have a lower energetic threshold for the B-to-Z transition than other sequences [10]. In prokaryotes, these sequences can also be found in plasmid DNA, and while long poly(dG-dC) tracts more preferentially form Z-DNA, shorter repeats may exist in a dynamic equilibrium with B-DNA [77]. Z-DNA contributes to structural integrity and nuclease resistance of biofilm eDNA [16] (Fig. 1B). While Z-DNA can be induced in vitro under various conditions like high salt [78], polycations [79], and oxidative modifications [80], its stability may require stabilizing proteins, with the best characterized examples being the bacterial DNA binding proteins (DNABII) [16]. These bacterial proteins localize at junction points within extracellular DNA lattice to crosslink DNA strands and confer mechanical robustness [16]. Clinical and experimental evidence highlight DNABII proteins as indispensable for biofilm maintenance: elevated DNABII expression has been reported in paediatric patient biofilm, contributing to its persistence, and antibodies targeting DNABII effectively disrupt implant-associated biofilms [81, 82]. Depletion of DNABII results in destabilization of biofilm [16]. Additionally, previous studies have revealed that HJs serve as crucial structural scaffolds for DNABII binding [83, 84]. The inability to restore biofilm integrity after DNABII depletion, even with the addition of nonspecific DNA-binding proteins, further emphasizes the specificity of DNABII–HJ interactions in matrix stability. Building on this, Buzzo et al. proposed a model in which DNABII proteins first stabilize HJs, generating torsional strain and closed DNA loops that favour B-to-Z transitions under supercoiling [16]. Indeed, co-crystal structures of DNABII proteins–DNA complexes show terminal nucleotides adopting anti-syn conformations characteristic of Z-DNA, supporting the idea that DNABII-stabilized HJs are critical to promote Z-DNA accumulation within the extracellular matrix. Interestingly, despite hemin’s specificity for G4s [11, 85], one study even reported that Z-DNA formation in the eDNA of S. epidermidis was abrogated in the absence of hemin [39]. In this system, G4s formed more readily than Z-DNA, raising the possibility that G4/hemin DNAzymes may facilitate Z-DNA nucleation, potentially through oxidative modifications such as 8-oxo-guanine formation, particularly in host-associated biofilms exposed to hemin and H2O2 during inflammation [16, 39, 86, 87]. However, Z-DNA has also been identified in contexts such as oral biofilms where free hemin is unlikely to be abundant, suggesting that additional, hemin-independent pathways likely contribute to its stabilization in microbial communities [75, 88].
Noncanonical secondary structures in NETs eDNA
Since their discovery in 2004, the lytic and vital pathways of NETosis, their compositions, and roles in responding to an invading pathogen have been extensively studied [14]. Despite the similarities between biofilms and NETs, the existence and roles of noncanonical secondary structures like G4s and Z-DNA remain largely unexplored [14, 89]. This is particularly interesting since >70 000 potential G4s and 391 sequence-prone Z-DNA-forming sites have been detected in the human genome, and NETs are formed in conditions of high salt or oxidative stress, among others, both of which are typical of inflammation and are demonstrated to induce or stabilize G4s and Z-DNA in vitro [80, 90–99].
We recently discovered G4 structures in NETs, exhibiting DNAzyme activity when complexed with hemin, producing ROS that promotes bactericidal effects (Fig. 1A). Inhibiting the DNAzyme with G4-specific ligands like BRACO19 and NMM or antioxidants such as vitamin C significantly abrogated pathogen killing [17]. This highlights the critical role of G4 in NETs with potent bactericidal activity. Conversely, G4s may also protect against oxidative degradation of the eDNA by the generated hydroxyl radicals through structural shielding and interaction with DNA repair enzymes [100, 101]. G4/hemin DNAzyme in NETs emerging as the critical driver of ROS potentiates other novel roles of G4s in the system, given that comparable functions have been discovered in biofilms.
To date, reported evidence for naturally occurring Z-DNA in NETs eDNA is absent, and Z-DNA from microbial DNA [102, 103] is implicated in eliciting immune responses in the host. NETs are an important host defence mechanism against biofilm-related infections. Interestingly, NETs eDNA can be converted from B-DNA to Z-DNA when stabilized by bacterial DNABII proteins, which offers adaptive benefits for biofilm to incorporate NETs eDNA into its EPS [16, 81] (Fig. 1B). Recent clinical evidence further suggests elevated DNABII expression in biofilms from paediatric patients, underscoring its relevance in vivo [81]. This reinforces biofilm’s structural integrity and effectively creates a protective niche against NETs killing by hijacking the host immune mechanism for its own benefit [16, 39]. It also highlights the propensity for Z-DNA formation in NETs eDNA under the right conditions, which may enhance the stability, protection, and persistence of NETs eDNA, thereby sustaining immune defence mechanisms against biofilms. For instance, such properties contribute to the formation of a ‘dead zone’ in the eye, effectively confining P. aeruginosa biofilms and preventing their dissemination to the brain [104]. A secondary defence mechanism by biofilms against NETs is the release of the bacterial nucleoid-associated protein, H-NS, as the eDNA matures from B- to Z-DNA, which not only prevents the formation of new NETs but also leads to the retraction of previously formed NETs, offering a unique edge to the spread of the pathogen [105].
Can Z-DNA naturally occur in NETs?
The process of NETosis, driven by oxidative stress and chromatin decondensation, creates an environment that is conducive for the formation of structures like G4 and Z-DNA through the formation of 8-oxo-guanine (8-oxoG) [80, 97–99]. These oxidative nucleotides, intracellularly repaired by the BER pathway primarily through the activity of 8-oxoguanine DNA glycosylase 1 (OGG1), are excised, creating abasic sites that serve as formation points for secondary structures like G4 and Z-DNA [106, 107]. Interestingly, the inhibition of early steps in BER, particularly OGG1 activity, suppresses neutrophil infiltration and spontaneous NETosis, suggesting NETosis and the pathway to the formation of noncanonical secondary structures are interconnected [7, 108]. Furthermore, Z-DNA formation has been implicated in chromatin remodelling during transcriptional activation by disruption and ejection of nucleosomes to maintain an open chromatin structure [109]. This phenomenon is particularly relevant in the context of NETosis, where chromatin decondensation and nucleosome eviction are fundamental processes enabling the release of nuclear DNA [110]. When histones dissociate and the DNA ends remain topologically constrained, regions of negative supercoiling may arise, creating favourable conditions for B-to-Z transition. Oxidative lesions may further promote this structural conversion. Additionally, mitochondrial DNA (mtDNA), released extracellularly alongside nuclear DNA during NETosis, has a closed circular genome rich with unmethylated CpG from its bacterial ancestry and is highly prone to torsional stress from supercoiling and oxidative damage, both favouring transition from B- to Z-DNA [111–114]. In addition, NETs must also function in DNase-rich blood (up to 0.356 U/ml in healthy individuals), where nuclease resistance is essential, and Z-DNA is ∼12% longer than B-DNA per bp and ∼37% longer per turn, potentially casting a wider net to enhance pathogen entrapment, presenting a favourable scenario for the existence of Z-DNA in NETs [115, 116], through stabilized nuclear aggregates of polyamines hypothesized in 2013 [117]. While the presence of these noncanonical secondary structures proves advantageous to the overall functioning of NETs, persistence of NETs can exacerbate inflammation, hinder NET clearance, and contribute to chronic diseases [118, 119]. Understanding the balance between their protective roles and pathological consequences remains essential for addressing NET-related immunopathologies.
eDNA structures contributing to immune modulation and pathologies
DNA is well-recognized as PAMPs or DAMPs, depending on its origin, structural features, or context of exposure. As a PAMP, DNA is typically derived from a microbial source, often containing unmethylated CpG motifs, along with other microbial components, marking it as foreign to the host immune system [120]. Conversely, DAMP DNA originates from the host itself, released during cell stress, injury, or death [121]. Contextual cues, including sequence features, ectopic location, chemical modifications, molecular complexes, or associated proteins, can render self-DNA immunogenic. PRRs, most notably Toll-like receptor 9, cyclic GMP-AMP synthase (cGAS), absent in melanoma 2 (AIM2), and ZBP-1, are endosomal or cytosolic immune sensors that can recognize these DNA signatures, leading to activation of type 1 interferons (IFN), inflammasomes, and necroptosis. However, immune recognition of eDNA would first require its internalization, via natural endocytosis or forming complexes with antibodies or DNA-binding proteins, into host cells before being sensed by PRRs.
Biofilm eDNA can act as a PAMP and trigger host immune responses. Endosomal TLR9 in macrophages and gingival fibroblasts was activated by periodontal biofilm eDNA, inducing inflammatory mediators and contributing to tissue degradation [122]. Pseudomonas aeruginosa biofilm eDNA could activate neutrophils marked by cytokine release, upregulation of activation markers, and enhanced phagocytosis and NETosis [104]. eDNA degradation by DNase I significantly attenuates these immune responses, reinforcing eDNA’s role as a key PAMP [123]. Interestingly, this neutrophil activation appears to occur independently of CpG and TLR9 signalling, suggesting alternative DNA sensors are involved. Although direct evidence remains lacking, possible candidates might include cGAS-STING–associated DNA receptors or other pattern recognition receptors yet to be characterized. Notably, recent reports have described the existence of cell surface TLR9 (sTLR9), which can bind CpG oligodeoxynucleotides; however, whether sTLR9 can directly initiate signal transduction remains uncertain. sTLR9 expression has been documented on neutrophils, B cells, and erythrocytes, raising the intriguing possibility that surface-localized DNA recognition contributes to biofilm eDNA sensing in vivo [124, 125].
Circumstantial evidence implicates noncanonical structures of biofilm’s eDNA as PAMPs. Z-DNA is an effective immunogen that can potently induce antibodies by immunization under conditions in which B-DNA is inactive [126]. Interestingly, Z-DNA-specific antibodies—thought to originate from potential biofilm exposure—have been detected not only in patients with autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), but also in the sera from healthy individuals [102]. In addition to antibody recognition, host recognition of extracellular Z-DNA is likely a key event, with Z-DNA binding protein 1 (ZBP1) representing a potential host innate immune sensor candidate. Although direct recognition of biofilm’s extracellular Z-DNA by host ZBP1 remains to be confirmed in vivo, ZBP1 plays a pivotal role in inducing inflammatory cell death and type I IFN responses during viral infections [127]. The presence of Z-DNA or Z-DNA–binding proteins in fungi has not yet been fully established; however, ZBP1 can detect fungal nucleic acids and promote inflammasome activation and PANoptosis, suggesting a potential link between fungal eDNA and Z-DNA–mediated immune recognition [128]. Similarly, despite the lack of direct evidence supporting G4 as a PAMP in biofilm eDNA, G4 in an unmethylated CpG oligomer can increase immunostimulation through activation of TLR9, which can bind and recognize G4 structures [129].
G4 and Z-DNA in biofilm’s eDNA can also modulate immune signalling. The physical properties of G4 and Z-DNA render them resistant to host nucleases, allowing biofilms to persist despite immune pressure [16, 39]. Chloroquine, a DNA intercalator that preferentially binds to B-DNA, has also been shown to bind to Z-DNA, reverting it to B-DNA, and restore DNase susceptibility and reduce biofilm mass [16, 75, 130, 131]. Conversely, the B- to Z-DNA transition mediated by DNABII enables mature biofilms to co-opt host NETs as protective barriers rather than immune effectors. At the same time, this conversion disrupts NET antimicrobial activity by displacing histones and neutralizing their bactericidal potential [16]. G4-eDNA, by forming higher-order biofilm structure, can not only shield the underlying bacterial PAMPs from recognition by PRRs, but G4s can also bind and sequester proinflammatory host molecules like hemin [11].
NETs are potent DAMPs that play a dual role in antimicrobial defence and immune modulation [132]. While NETs effectively trap and eliminate pathogens, excessive NET formation or reduced clearance can lead to tissue damage and systemic inflammation. This can be mediated by the release of histones, ROS, and proteases, as well as the eDNA itself, engaging in multiple arms of the innate immune system [132, 133]. NETs eDNA is known to trigger various proinflammatory cytokines via TLR9 or cGAS in immune cells. Though unconfirmed by direct evidence in the context of NETosis, mtDNA released from mitochondria into cytoplasm or extracellularly under oxidative or genotoxic stress in various biological contexts has been shown to adopt Z-conformation and serve as a structural DAMP, engaging ZBP-1 and cGAS, which can promote proinflammatory responses and necroptotic cell death [134]. For instance, in keratinocytes exposed to ultraviolet radiation, the accumulation of mitochondrial-derived Z-DNA correlates with heightened Type 1 IFN production compared to B-DNA. This immune response, however, is mitigated when ZBP-1 is knocked down, indicating that ZBP1 functions as the sensor mediating IFN induction downstream of Z-DNA recognition. Moreover, the G4/hemin DNAzyme in NETs eDNA was shown to be the primary producer of the hydroxyl radical, the most potent ROS, which indiscriminately causes oxidative damage and can lead to haemolysis of red blood cells or other tissues in the vicinity [17]. Another critical factor contributing to imbalance is the accumulation of DNA–histone complexes and protein-associated DNA in the extracellular space due to insufficient DNase activity [119, 135]. Under normal conditions, DNase I degrades naked B-DNA, while DNase1L3 specifically targets protein-bound DNA in NETs, preventing excessive immune activation [136, 137]. However, G4s, and potentially Z-DNA, in NETs can enhance their resistance to degradation, prolonging their immune engagement [16, 39] (Fig. 1B). In fact, the presence of a nuclease-resistant G4 showed a 10-fold increase in the uptake of a CpG oligonucleotide by human B lymphocyte cell lines, resulting in more than double the amount of IL-6 produced [138]. This resistance to degradation may worsen systemic inflammation, tissue damage, and organ dysfunction and drive autoimmune diseases.
NETs and their impaired clearance have been implicated in autoimmune conditions like SLE through multiple lines of evidence. Autoantibodies against nucleic acids and excessive type I IFN are hallmarks of SLE. Internalization of SLE immune complexes containing nucleic acids by plasmacytoid dendritic cells (pDCs) induces endosomal TLR9 activation and type I IFN production [139]. Besides double-stranded DNA, SLE autoantibodies also recognize other components of NETs, such as histones, antimicrobial peptides, MPO, and proteinase 3, suggesting the direct role for NETs in the initiation and perpetuation of SLE via the generation of autoantigens [140, 141]. Specific posttranslational modifications of histones on NETs have already been identified as immunogens of SLE. Hydroxyl radicals, likely including those generated by the G4/hemin DNAzyme of NETs eDNA, can give rise to various posttranslational modifications like hydroxylation, sulfoxidation, and carbonylation of NET-associated proteins that could become immunogenic [142]. In addition, antigenic complexes made up of NET-derived eDNA and antimicrobial peptides like LL-37 have been shown to reduce NET clearance and drive chronic inflammation through the activation of pDCs and autoantibody production via memory B cells in SLE patients [143, 144]. Interestingly, LL-37, a cationic amphipathic antimicrobial peptide from the cathelicidin family, can potentially form an antigenic complex with Z-DNA both through charge as well as its alpha helical structure. Moreover, neutrophils from SLE patients, particularly low-density granulocytes, are prone to produce more NETs with enriched oxidized eDNA, which can not only impair nuclease degradation but also increase their sensing by the cGAS pathway, further augmenting interferongenic responses [145, 146]. As noted previously, oxidized nucleic acid is prone to B-to-Z transformation. Besides excess formation of NETs, many SLE patients have impaired ability to degrade these structures due to aberrant levels or functions of DNases [147]. Additionally, ZBP-1, a key inducer of type 1 IFN response, has been found to be significantly upregulated in patients with SLE compared to healthy individuals [148]. Along with expression of autoantibodies against DNA, patients with SLE—and even healthy subjects—express anti-Z-DNA antibodies, which, to date, are thought to originate in response to extracellular Z-DNA from biofilms [102, 149]. Given the conjectural evidence presented above and the prevalence of anti-Z-DNA antibodies in healthy individuals, we propose that NET-derived Z-DNA is an endogenous source of autoantigens, which may play a central role in SLE pathogenesis. Additional research is needed to clarify the mechanisms underlying immune tolerance to these autoantigens in healthy individuals and how disruptions in these processes contribute to the development of autoimmunity like SLE.
In addition to being proinflammatory, NETs have also been implicated in being prothrombotic, with elevated NET levels in COVID-19 patients correlating with heightened thrombotic events [150, 151]. Specifically, since the NETs eDNA is anionic, it activates the contact pathway and has been shown to directly interact with thrombin, especially at exosite II [152, 153]. While direct evidence is absent, a mixed duplex and G4-forming aptamer, HD22, showed specificity for exosite II with potential allosteric activation of thrombin and procoagulant effects on fibrin formation, highlighting a potential role for noncanonical secondary structures in NETs eDNA regulating thrombosis, further emphasizing the need for directed investigations [154, 155].
Targeting noncanonical secondary structures: potential therapeutic implications and beyond
G4s and Z-DNA in the eDNA confer enhanced stability, immune evasion or dysregulation, and resistance to nuclease-mediated degradation in both biofilms and NETs, contributing to chronic infection, persistent inflammation, and autoimmune pathology. Targeting these noncanonical structures offers a promising strategy to disrupt pathological biofilm integrity and limit excessive NET accumulation without significantly impairing antimicrobial defences.
One strategy to disrupt biofilm is to leverage G4 DNAzymes. Inducing peroxidase activity within biofilms via G4/hemin can generate ROS, effectively kill bacteria, and disrupt biofilms [17, 39, 156]. This effect may be potentiated with DNAzyme enhancers like spermine or chitosan, as well as G4 stabilizers, particularly when combined with antibiotics that are tolerant to H2O2 to improve biofilm penetration and achieve synergistic outcomes [27, 157, 158]. Conversely, spermine may stabilize Z-DNA, strengthening the biofilm matrix; hence, further experimental validation is required to determine whether DNAzyme potentiation or Z-DNA stabilization is facilitated by spermine treatment [33]. A study utilizing G4 hydrogel as a potential nonantibiotic wound dressing for biofilm infections demonstrated that the supply of hemin and H₂O₂ from the hydrogel activated ROS mediated by G4 rapidly eradicated biofilm infections and improved healing in a diabetic wound mouse model [156].
Instead of exploiting the enzymatic activity of G4 in biofilms, an alternative approach is to destabilize the G4 structure, rendering the extracellular DNA more susceptible to nuclease digestion. Small molecules, such as TMPyP4, a porphyrin-based molecule known to intercalate into G4-DNA, can disrupt G4 when used at specific concentrations that favour unwinding rather than stabilization [159–161]. Antisense oligonucleotides, complementary to the G4-forming strand, can also be strategically designed and have been shown to unwind G4 structures found in telomeres and promoters [162, 163]. Although direct evidence in biofilm is limited, helicases are also known to unwind G4 structures [164, 165]. Examples include members of the RecQ, XPD, Pif1, and DEAH box family helicases [166, 167]. Fracchioni et al. recently provided an in-depth review of emerging strategies for selectively unfolding G4s, highlighting their potential to modulate G4 biological functions and enhance therapeutic applications [163].
Given Z-DNA’s role in providing stability to biofilms, therapies targeting Z-DNA directly and its stabilizing proteins aim to disrupt its secondary structure, ultimately inducing collapse. An emerging therapeutic that targets Z-DNA is chloroquine, an antimalarial and immunosuppressant drug that is commonly used for treating disorders like SLE [130, 168]. Chloroquine stabilizes DNA in its B-form, effectively disrupting Z-DNA-dependent biofilm stability by inhibiting the B-to-Z DNA transition [169]. By preferentially binding to Z-DNA-forming sequences, chloroquine reduces Z-DNA content and mature biofilm mass, shifting bacteria to their planktonic state and restoring mature biofilm’s susceptibility to DNase [16]. Interestingly, mechanical testing showed that chloroquine-treated biofilms had significantly lowered stiffness, indicating disrupted biofilm EPS, whereas DNase treatment increased stiffness by depleting B-DNA, consistent with the notion that a greater proportion of B-DNA contributes to a more flexible biofilm matrix. A recent Streptococcus mutans biofilm study showed that eDNA resistant to DNase I could be effectively degraded when DNase I was combined with chloroquine, emphasizing the translational potential of targeting noncanonical DNA structures in biofilm [75]. In addition, Holliday junction resolvase RusA, which cleaves crossover DNA structures, has demonstrated potential for Z-DNA elimination, owing likely to the dependence on HJs for the stabilization of vertices by DNABII and formation of Z-DNA in the biofilm [16, 170]. Additionally, due to the thermodynamically unstable nature of Z-DNA, stabilizer proteins (DNABII), such as HU and IHF, stabilize Z-DNA within biofilms and provide promising targets for indirectly collapsing Z-DNA in biofilms [171]. Targeting these proteins with monoclonal antibodies (e.g. CMTX-101, TRL1068) destabilizes Z-DNA, collapsing biofilms and restoring antibiotic susceptibility [171, 172]. NETs, unlike biofilms, form an integral part of the immune response to trap and kill pathogens and should not be abrogated. Current therapies, such as anti-TNF treatments, often target neutrophil function but carry risks like neutropenia and increased susceptibility to infections [173, 174]. Completely inhibiting NETosis can also weaken innate immune defences, as seen in cases like ocular P. aeruginosa biofilm infections, where NET inhibition led to bacterial migration and worsened outcomes [104]. Given this challenge, therapies should prioritize enhancing NET clearance over complete suppression; hence, we propose targeting the secondary structures of NETs eDNA to reduce undue effects from their excessive accumulation. These structures may be destabilized by modulating environmental factors such as ionic strength and oxidative stress, or via engineered nucleases specifically targeting G4 or Z-DNA [80, 99, 175, 176]. Alternatively, the degradation of Z-DNA may be influenced by the activity of DNA unwinding enzymes, particularly topoisomerases. Topoisomerases, known for their ability to resolve DNA supercoiling, indirectly modulate Z-DNA stability by relaxing negative superhelical stresses in B-DNA. This relaxation would prevent DNA from shifting into the Z-form, thereby reducing the presence of Z-DNA structures and rendering NET-derived eDNA less resistant to DNase degradation [177]. Combining these approaches—targeted nucleases, DNA unwinding strategies, and environmental modulation—presents a unified framework for mitigating NET-driven inflammation. By preserving NETs' protective functions while preventing their pathological effects, these strategies could lead to more precise and effective treatments for a wide range of immune disorders.
Conclusions and future research
Despite limited but growing evidence, Z-DNA and G4 structures remain the best-characterized noncanonical conformations in extracellular DNA of biofilms and NETs. Nonetheless, several questions arise about these noncanonical structures in the two systems (Panel). Interestingly, while G4s present in NETs eDNA play a major role in killing invading pathogens; however, when complexed with hemin, the same complex in biofilm eDNA works towards detoxifying ROS and facilitating EET when anoxic. The contextual evolution of the same DNAzyme in antithetical systems suggests a less understood ‘arms race’. Additionally, discovering Z-DNA in NETs eDNA offers a paradigm shift in the understanding of the immunopathogenesis of SLE. It explains finding anti-Z-DNA antibodies in healthy individuals and questions biofilm eDNA as the antigen; it also warrants further studies into the body’s tolerance mechanisms towards its own highly immunostimulatory Z-DNA. Finally, given the immunomodulatory roles these structures play, it is of utmost importance to target these structures specifically to facilitate rapid clearance of these eDNA systems. Hence, G4 and Z-DNA likely act as a double-edged sword whose effects are delicately balanced by timely clearance of the eDNA in these systems.
Panel
Outstanding questions
-
Can stable non-canonical secondary structures be formed in the eDNA of biofilms and NETs?
What are the shared structures between the two systems, and do they have similar or divergent functions in each system?
What are the key factors that stabilize these alternative structures in each system?
-
Do non-canonical structures have novel roles in the eDNA that are distinct from their intended intracellular roles?
Are the non-canonical secondary structures the underlying engine providing the bioactivity to the eDNA in biofilms and NETs?
Are there variations in the numbers of the non-canonical secondary structures formed in the eDNA dependent on environmental cues?
Do they adapt functionally in response to perturbations in the environment?
-
How do non-canonical secondary structures in eDNA facilitate or mitigate hostile interactions between NETs and biofilms?
Is there structural complementarity between non-canonical eDNA structures in NETs and biofilms that enables physical co-assembly or cross-organization of their matrices?
Could mixed DNA structures interfere with innate immune sensing, leading to immune tolerance or inappropriate activation?
-
Can non-canonical secondary structures of these systems act as effectors of immunomodulation?
Can naked non-canonical secondary structures act as DAMPs or PAMPs?
Are circumstances and contextual cues important for recognition and internalization of these non-canonical secondary structures?
-
Do non-canonical structures in the eDNA of NETs play a role in immunopathologies?
Are non-B structures more immunostimulatory? What is the mechanism of tolerance to self-non-B structures in eDNA of NETs?
What are their roles in thrombus formation?
-
Can targeting these core non-canonical structures offer novel therapeutic modalities to treat biofilm- and NET-related pathologies?
Can leveraging versus destroying the non-canonical secondary structures in the biofilm eDNA offer an antibiotic synergistic/free strategy to disrupt biofilms?
How can NETs be cleared by neutralizing the non-canonical secondary structures without compromising their immune defensive response?
Acknowledgements
The graphical abstract was created with BioRender. Demir, T.D. (2025) https://BioRender.com/8du8tc9.
Author contributions: Tevriz Dilan Demir (Conceptualization [equal], Writing – original draft [equal]), Satoe Azechi-Ogawa (Conceptualization [equal], Writing – original draft [equal]), Nikhil Ram-Mohan (Conceptualization [equal], Writing – original draft [equal]), and Samuel Yang (Conceptualization [equal], Writing – original draft [equal], Writing – review & editing [equal])
Contributor Information
Tevriz Dilan Demir, Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, United States.
Satoe Azechi-Ogawa, Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, United States.
Nikhil Ram-Mohan, Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, United States.
Samuel Yang, Department of Emergency Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, United States.
Conflict of interest
None declared.
Funding
The authors received no financial support from this research.
Data availability
No new data were generated or analysed in support of this research.
References
- 1. Marsico G, Chambers VS, Sahakyan AB et al. Whole genome experimental maps of DNA G-quadruplexes in multiple species. Nucleic Acids Res. 2019;47:3862–74. 10.1093/nar/gkz179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Yella VR, Vanaja A. Computational analysis on the dissemination of non-B DNA structural motifs in promoter regions of 1180 cellular genomes. Biochimie. 2023;214:101–11. 10.1016/j.biochi.2023.06.002. [DOI] [PubMed] [Google Scholar]
- 3. Makova KD, Weissensteiner MH. Noncanonical DNA structures are drivers of genome evolution. Trends Genet. 2023;39:109–24. 10.1016/j.tig.2022.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Bansal A, Kaushik S, Kukreti S. Non-canonical DNA structures: diversity and disease association. Front Genet. 2022;13:959258. 10.3389/fgene.2022.959258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Luo Y, Granzhan A, Marquevielle J et al. Guidelines for G-quadruplexes: I. In vitro characterization. Biochimie. 2023;214:5–23. 10.1016/j.biochi.2022.12.019. [DOI] [PubMed] [Google Scholar]
- 6. Ravichandran S, Subramani VK, Kim KK. Z-DNA in the genome: from structure to disease. Biophys Rev. 2019;11:383–7. 10.1007/s12551-019-00534-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Zhang W, Zhong R, Qu X et al. Effect of 8-hydroxyguanine DNA glycosylase 1 on the function of immune cells. Antioxidants. 2023;12:1300. 10.3390/antiox12061300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Vianney YM, Jana J, Schröder N et al. Nucleic acid structure and biology. In: Nucleic Acid Biology and Its Application in Human Diseases. Singapore: Springer Nature, 2023, 1–34. 10.1007/978-981-19-8520-1. [DOI] [Google Scholar]
- 9. Del Mundo IMA, Vasquez KM, Wang G. Modulation of DNA structure formation using small molecules. Biochim Biophys Acta Mol Cell Res. 2019;1866:118539. 10.1016/j.bbamcr.2019.118539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Choi J, Majima T. Conformational changes of non-B DNA. Chem Soc Rev. 2011;40:5893–909. 10.1039/c1cs15153c. [DOI] [PubMed] [Google Scholar]
- 11. Gray LT, Puig Lombardi E, Verga D et al. G-quadruplexes sequester free heme in living cells. Cell Chemical Biology. 2019;26:1681–91. 10.1016/j.chembiol.2019.10.003e5. [DOI] [PubMed] [Google Scholar]
- 12. Monticolo F, Palomba E, Termolino P et al. The role of DNA in the extracellular environment: a focus on NETs, RETs and biofilms. Front Plant Sci. 2020;11:589837. 10.3389/fpls.2020.589837. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Whitchurch CB, Tolker-Nielsen T, Ragas PC et al. Extracellular DNA required for bacterial biofilm formation. Science. 2002;295:1487. 10.1126/science.295.5559.1487. [DOI] [PubMed] [Google Scholar]
- 14. Brinkmann V, Reichard U, Goosmann C et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532–5. 10.1126/science.1092385. [DOI] [PubMed] [Google Scholar]
- 15. Seviour T, Winnerdy FR, Wong LL et al. The biofilm matrix scaffold of Pseudomonas aeruginosa contains G-quadruplex extracellular DNA structures. npj Biofilms Microbiomes. 2021;7:27. 10.1038/s41522-021-00197-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Buzzo JR, Devaraj A, Gloag ES et al. Z-form extracellular DNA is a structural component of the bacterial biofilm matrix. Cell. 2021;184:5740–58. 10.1016/j.cell.2021.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Ku T-H, Ram-Mohan N, Zudock EJ et al. Neutrophil extracellular traps have active DNAzymes that promote bactericidal activity. Nucleic Acids Res. 2025;53:gkae1262. 10.1093/nar/gkae1262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Hou Y, Li F, Zhang R et al. Integrative characterization of G-quadruplexes in the three-dimensional chromatin structure. Epigenetics. 2019;14:894–911. 10.1080/15592294.2019.1621140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Biver T. Discriminating between parallel, anti-parallel and hybrid G-quadruplexes: mechanistic details on their binding to small molecules. Molecules. 2022;27:4165. 10.3390/molecules27134165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Cang X, Šponer J, Cheatham TE 3rd. Explaining the varied glycosidic conformational, G-tract length and sequence preferences for anti-parallel G-quadruplexes. Nucleic Acids Res. 2011;39:4499–512. 10.1093/nar/gkr031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Ito Y, Sun T, Tanaka H et al. Tissue sodium accumulation induces organ inflammation and injury in chronic kidney disease. Int J Mol Sci. 2023;24:8329. 10.3390/ijms24098329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Flemming H-C, van Hullebusch ED, Neu TR et al. The biofilm matrix: multitasking in a shared space. Nat Rev Micro. 2023;21:70–86. 10.1038/s41579-022-00791-0. [DOI] [PubMed] [Google Scholar]
- 23. Çam S, Badıllı İ. The effect of NaCl, pH, and phosphate on biofilm formation and exopolysaccharide production by high biofilm producers of Bacillus strains. Folia Microbiol (Praha). 2024;69:613–24. [DOI] [PubMed] [Google Scholar]
- 24. Travascio P, Li Y, Sen D. DNA-enhanced peroxidase activity of a DNA-aptamer-hemin complex. Chem Biol. 1998;5:505–17. 10.1016/S1074-5521(98)90006-0. [DOI] [PubMed] [Google Scholar]
- 25. Wen L-N, Xie M-X. Evidence of different G-quadruplex DNA binding with biogenic polyamines probed by electrospray ionization-quadrupole time of flight mass spectrometry, circular dichroism and atomic force microscopy. Biochimie. 2013;95:1185–95. 10.1016/j.biochi.2013.01.006. [DOI] [PubMed] [Google Scholar]
- 26. Gil-Martínez A, Galiana-Roselló C, Lázaro-Gómez A et al. Deciphering the interplay between G-quadruplexes and natural/synthetic polyamines. ChemBioChem. 2025;26:e202400873. 10.1002/cbic.202400873. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Adeoye RI, Ralebitso-Senior TK, Boddis A et al. Spermine enhances the peroxidase activities of multimeric antiparallel G-quadruplex DNAzymes. Biosensors. 2025;15:12. 10.3390/bios15010012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Santos T, Salgado GF, Cabrita EJ et al. G-quadruplexes and their ligands: biophysical methods to unravel G-quadruplex/ligand interactions. Pharmaceuticals. 2021;14:769. 10.3390/ph14080769 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Ha SC, Choi J, Hwang H-Y et al. The structures of non-CG-repeat Z-DNAs co-crystallized with the Z-DNA-binding domain, hZ alpha(ADAR1). Nucleic Acids Res. 2009;37:629–37. 10.1093/nar/gkn976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Run Y, Tavakoli M, Zhang Y et al. Formation and biological implications of Z-DNA. Trends Genet. 2025. 10.1016/j.tig.2025.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Rich A, Zhang S. Timeline: Z-DNA: the long road to biological function. Nat Rev Genet. 2003;4:566–72. 10.1038/nrg1115. [DOI] [PubMed] [Google Scholar]
- 32. Yi J, Yeou S, Lee NK. DNA bending force facilitates Z-DNA formation under physiological salt conditions. J Am Chem Soc. 2022;144:13137–45. 10.1021/jacs.2c02466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Zhao C, Ma Y, Zhang M et al. Polyamine metabolism controls B-to-Z DNA transition to orchestrate DNA sensor cGAS activity. Immunity. 2023;56:2508–22. 10.1016/j.immuni.2023.09.012. [DOI] [PubMed] [Google Scholar]
- 34. Misra VK, Honig B. The electrostatic contribution to the B to Z transition of DNA. Biochemistry. 1996;35:1115–24. 10.1021/bi951463y. [DOI] [PubMed] [Google Scholar]
- 35. Hettiarachchi E, Grassian VH. pH-dependent surface interactions and structural changes for DNA adsorbed on TiO2 particle surfaces have implications for environmental DNA. Cell Rep Phys Sci. 2025;6:102716. 10.1016/j.xcrp.2025.102716. [DOI] [Google Scholar]
- 36. Yang D, Sun R, Sun H et al. A FRET biosensor constructed using pH sensitive G-quadruplex DNA for detecting mitochondrial autophagy. Talanta. 2025;281:126885. 10.1016/j.talanta.2024.126885. [DOI] [PubMed] [Google Scholar]
- 37. Manzoli FA, Muchmore JH, Bonora B et al. Lipid–DNA interactions. II. Phospholipids, cholesterol, glycerophosphorylcholine, spingosine and fatty acids. Biochim Biophys Acta. 1974;340:1–15. 10.1016/0005-2787(74)90169-5. [DOI] [PubMed] [Google Scholar]
- 38. Vialet B, Gissot A, Delzor R et al. Controlling G-quadruplex formation via lipid modification of oligonucleotide sequences. Chem Commun. 2017;53:11560–3. 10.1039/C7CC05693A. [DOI] [PubMed] [Google Scholar]
- 39. Minero GAS, Møllebjerg A, Thiesen C et al. Extracellular G-quadruplexes and Z-DNA protect biofilms from DNase I, and G-quadruplexes form a DNAzyme with peroxidase activity. Nucleic Acids Res. 2024;52:1575–90. 10.1093/nar/gkae034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Ibáñez de Aldecoa AL, Zafra O, González-Pastor JE. Mechanisms and regulation of extracellular DNA release and its biological roles in microbial communities. Front Microbiol. 2017;8:1390. 10.3389/fmicb.2017.01390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Steinberger RE, Holden PA. Extracellular DNA in single- and multiple-species unsaturated biofilms. Appl Environ Microb. 2005;71:5404–10. 10.1128/AEM.71.9.5404-5410.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Sharma DK, Rajpurohit YS. Multitasking functions of bacterial extracellular DNA in biofilms. J Bacteriol. 2024;206:e0000624. 10.1128/jb.00006-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Smithies WR, Gibbons NE. The deoxyribose nucleic acid slime layer of some halophilic bacteria. Can J Microbiol. 1955;1:614–21. 10.1139/m55-074. [DOI] [PubMed] [Google Scholar]
- 44. Liu S, Le Mauff F, Sheppard DC et al. Filamentous fungal biofilms: conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus. npj Biofilms Microbiomes. 2022;8:83. 10.1038/s41522-022-00347-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Rajendran R, Williams C, Lappin DF et al. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Euk Cell. 2013;12:420–9. 10.1128/EC.00287-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Yang K, Wang L, Cao X et al. The origin, function, distribution, quantification, and research advances of extracellular DNA. Int J Mol Sci. 2022;23:13690. 10.3390/ijms232213690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Turnbull L, Toyofuku M, Hynen AL et al. Explosive cell lysis as a mechanism for the biogenesis of bacterial membrane vesicles and biofilms. Nat Commun. 2016;7:11220. 10.1038/ncomms11220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Allesen-Holm M, Barken KB, Yang L et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol. 2006;59:1114–28. 10.1111/j.1365-2958.2005.05008.x. [DOI] [PubMed] [Google Scholar]
- 49. Thomas VC, Hiromasa Y, Harms N et al. A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol Microbiol. 2009;72:1022–36. 10.1111/j.1365-2958.2009.06703.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Hsu C-Y, Lin M-H, Chen C-C et al. Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. FEMS Immunol Med Microbiol. 2011;63:236–47. 10.1111/j.1574-695X.2011.00846.x. [DOI] [PubMed] [Google Scholar]
- 51. Okshevsky M, Meyer RL. The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms. Crit Rev Microbiol. 2015;41:341–52. 10.3109/1040841X.2013.841639. [DOI] [PubMed] [Google Scholar]
- 52. Mavridou DAI, Gonzalez D, Kim W et al. Bacteria use collective behavior to generate diverse combat strategies. Curr Biol. 2018;28:345–55. 10.1016/j.cub.2017.12.030. [DOI] [PubMed] [Google Scholar]
- 53. Teschler JK, Jiménez-Siebert E, Jeckel H et al. VxrB influences antagonism within biofilms by controlling competition through extracellular matrix production and type 6 secretion. mBio. 2022;13:e0188522. 10.1128/mbio.01885-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Gödeke J, Paul K, Lassak J et al. Phage-induced lysis enhances biofilm formation in Shewanella oneidensis MR-1. ISME J. 2011;5:613–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Wang D, Yu JM, Dorosky RJ et al. The phenazine 2-hydroxy-phenazine-1-carboxylic acid promotes extracellular DNA release and has broad transcriptomic consequences in Pseudomonas chlororaphis 30-84. PLoS One. 2016;11:e0148003. 10.1371/journal.pone.0148003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Brüssow H, Hendrix RW. Phage genomics: small is beautiful. Cell. 2002;108:13–6. [DOI] [PubMed] [Google Scholar]
- 57. Henriksen K, Rørbo N, Rybtke ML et al. P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination. Pathog Dis. 2019;77:ftz011. 10.1093/femspd/ftz011. [DOI] [PubMed] [Google Scholar]
- 58. Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134–47. 10.1038/nri.2017.105. [DOI] [PubMed] [Google Scholar]
- 59. Alhede M, Alhede M, Qvortrup K et al. The origin of extracellular DNA in bacterial biofilm infections in vivo. Pathog Dis. 2020;78:ftaa018. 10.1093/femspd/ftaa018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Flemming H-C, Wingender J. The biofilm matrix. Nat Rev Micro. 2010;8:623–33. 10.1038/nrmicro2415. [DOI] [PubMed] [Google Scholar]
- 61. Dengler V, Foulston L, DeFrancesco AS et al. An electrostatic net model for the role of extracellular DNA in biofilm formation by Staphylococcus aureus. J Bacteriol. 2015;197:3779–87. 10.1128/JB.00726-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Böhning J, Tarafder AK, Bharat TAM. The role of filamentous matrix molecules in shaping the architecture and emergent properties of bacterial biofilms. Biochem J. 2024;481:245–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Thomas CM, Nielsen KM. Mechanisms of, and barriers to, horizontal gene transfer between bacteria. Nat Rev Micro. 2005;3:711–21. 10.1038/nrmicro1234. [DOI] [PubMed] [Google Scholar]
- 64. Saunders SH, Tse ECM, Yates MD et al. Extracellular DNA promotes efficient extracellular electron transfer by pyocyanin in Pseudomonas aeruginosa biofilms. Cell. 2020;182:919–32. 10.1016/j.cell.2020.07.006e19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Maqbool T, Cho J, Shin KH et al. Using stable isotope labeling approach and two dimensional correlation spectroscopy to explore the turnover cycles of different carbon structures in extracellular polymeric substances. Water Res. 2020;170:115355. 10.1016/j.watres.2019.115355. [DOI] [PubMed] [Google Scholar]
- 66. Minero GAS, Lund LM, Klausen LH et al. Secret life of prophages: template-directed synthesis of DNA superstructures via prophage activation and rolling circle replication in bacterial biofilms. bioRxiv, 10.64898/2025.12.02.691978, 03 December 2025, preprint: not peer reviewed. [DOI] [Google Scholar]
- 67. Yang Q-F, Wang X-R, Wang Y-H et al. G4LDB 3.0: a database for discovering and studying G-quadruplex and i-motif ligands. Nucleic Acids Res. 2025;53:D91–8. 10.1093/nar/gkae835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Gambino M, Cappitelli F. Mini-review: biofilm responses to oxidative stress. Biofouling. 2016;32:167–78. 10.1080/08927014.2015.1134515. [DOI] [PubMed] [Google Scholar]
- 69. Cáp M, Váchová L, Palková Z. Reactive oxygen species in the signaling and adaptation of multicellular microbial communities. Oxid Med Cell Longev. 2012;2012:976753. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Sarmistha P, Khushnood F, Velayutham R et al. Triazolyl dibenzo[a, c]phenazines stabilize telomeric G-quadruplex and inhibit telomerase. Asian J Org Chem. 2021;10:2921–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Ajunwa OM, Minero GAS, Jensen SD et al. Hemin-binding DNA structures on the surface of bacteria promote extracellular electron transfer. Nucleic Acids Res. 2025;53:gkaf790. 10.1093/nar/gkaf790. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Cohen H, Sapir T, Borovok N et al. Polarizability of G4-DNA observed by electrostatic force microscopy measurements. Nano Lett. 2007;7:981–6. 10.1021/nl070013b. [DOI] [PubMed] [Google Scholar]
- 73. Livshits GI, Stern A, Rotem D et al. Long-range charge transport in single G-quadruplex DNA molecules. Nature Nanotech. 2014;9:1040–6. 10.1038/nnano.2014.246. [DOI] [PubMed] [Google Scholar]
- 74. Kotoky R, Ajunwa OM, Kawaichi S et al. Extracellular RNA drives electromethanogenesis in a methanogenic archaeon. bioRxiv, 10.1101/2025.07.06.663362, 06 July 2025, preprint: not peer reviewed. [DOI] [Google Scholar]
- 75. Evans DCS, Kristensen MF, Minero GAS et al. Dental biofilms contain DNase I-resistant Z-DNA and G-quadruplexes but alternative DNase overcomes this resistance. npj Biofilms Microbiomes. 2025;11:80. 10.1038/s41522-025-00694-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Yau HCL, Malekpour AK, Momin NG et al. Removal of eDNA from fabrics using a novel laundry DNase revealed using high-resolution imaging. Sci Rep. 2021;11:21542. 10.1038/s41598-021-98939-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Kim J, Yang C, DasSarma S. Analysis of left-handed Z-DNA formation in short d(CG)n sequences in Escherichia coli and Halobacterium halobium plasmids. Stabilization by increasing repeat length and DNA supercoiling but not salinity. J Biol Chem. 1996;271:9340–6. 10.1074/jbc.271.16.9340. [DOI] [PubMed] [Google Scholar]
- 78. Wang AH, Quigley GJ, Kolpak FJ et al. Molecular structure of a left-handed double helical DNA fragment at atomic resolution. Nature. 1979;282:680–6. 10.1038/282680a0. [DOI] [PubMed] [Google Scholar]
- 79. Shimada N, Kano A, Maruyama A. B–Z DNA transition triggered by a cationic comb-type copolymer. Adv Funct Mater. 2009;19:3590–5. [Google Scholar]
- 80. Fleming AM, Burrows CJ. Interplay of guanine oxidation and G-quadruplex folding in gene promoters. J Am Chem Soc. 2020;142:1115–36. 10.1021/jacs.9b11050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Hofer LK, Jurcisek JA, Elmaraghy C et al. Z-form extracellular DNA in pediatric CRS may provide a mechanism for recalcitrance to treatment. Laryngoscope. 2024;134:1564–71. 10.1002/lary.30986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Martyn L, Sethia R, Chon R et al. Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms. Laryngoscope. 2020;130:1364–71. 10.1002/lary.28188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Devaraj A, Buzzo JR, Mashburn-Warren L et al. The extracellular DNA lattice of bacterial biofilms is structurally related to Holliday junction recombination intermediates. Proc Natl Acad Sci USA. 2019;116:25068–77. 10.1073/pnas.1909017116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Devaraj A, Novotny LA, Robledo-Avila FH et al. The extracellular innate-immune effector HMGB1 limits pathogenic bacterial biofilm proliferation. J Clin Invest. 2021;131:e140527. 10.1172/JCI140527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Stadlbauer P, Islam B, Otyepka M et al. Insights into G-quadruplex-hemin dynamics using atomistic simulations: implications for reactivity and folding. J Chem Theory Comput. 2021;17:1883–99. 10.1021/acs.jctc.0c01176. [DOI] [PubMed] [Google Scholar]
- 86. Gouveia Z, Carlos AR, Yuan X et al. Characterization of plasma labile heme in hemolytic conditions. FEBS J. 2017;284:3278–301. 10.1111/febs.14192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Clifford DP, Repine JE. Hydrogen peroxide mediated killing of bacteria. Mol Cell Biochem. 1982;49:143–9. 10.1007/BF00231175. [DOI] [PubMed] [Google Scholar]
- 88. Han SL, Wang J, Wang HS et al. Extracellular Z-DNA enhances cariogenicity of biofilm. J Dent Res. 2025;104:774–83. 10.1177/00220345251316822. [DOI] [PubMed] [Google Scholar]
- 89. Yipp BG, Kubes P. NETosis: how vital is it?. Blood. 2013;122:2784–94. 10.1182/blood-2013-04-457671. [DOI] [PubMed] [Google Scholar]
- 90. Thiam HR, Wong SL, Wagner DD et al. Cellular mechanisms of NETosis. Annu Rev Cell Dev Biol. 2020;36:191–218. 10.1146/annurev-cellbio-020520-111016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Halverson TWR, Wilton M, Poon KKH et al. DNA is an antimicrobial component of neutrophil extracellular traps. PLoS Pathog. 2015;11:e1004593. 10.1371/journal.ppat.1004593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Retter A, Singer M, Annane D. ‘The NET effect’: neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis. Crit Care. 2025;29:59. 10.1186/s13054-025-05283-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Cicco S, Cicco G, Racanelli V et al. Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment. Mediators Inflamm. 2020;2020:1. 10.1155/2020/7527953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Monteith AJ, Miller JM, Maxwell CN et al. Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens. Sci Adv. 2021;7:eabj2101. 10.1126/sciadv.abj2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Chambers VS, Marsico G, Boutell JM et al. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nat Biotechnol. 2015;33:877–81. 10.1038/nbt.3295. [DOI] [PubMed] [Google Scholar]
- 96. Shin S-I, Ham S, Park J et al. Z-DNA-forming sites identified by ChIP-Seq are associated with actively transcribed regions in the human genome. DNA Res. 2016;23:477–86. 10.1093/dnares/dsw031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97. Tibrewal S, Ivanir Y, Sarkar J et al. Hyperosmolar stress induces neutrophil extracellular trap formation: implications for dry eye disease. Invest Ophthalmol Vis Sci. 2014;55:7961–9. 10.1167/iovs.14-15332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98. Azzouz D, Khan MA, Palaniyar N. ROS induces NETosis by oxidizing DNA and initiating DNA repair. Cell Death Discov. 2021;7:113. 10.1038/s41420-021-00491-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Wu S, Jiang L, Lei L et al. Crosstalk between G-quadruplex and ROS. Cell Death Dis. 2023;14:37. 10.1038/s41419-023-05562-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Pavlova AV, Kubareva EA, Monakhova MV et al. Impact of G-quadruplexes on the regulation of genome integrity, DNA damage and repair. Biomolecules. 2021;11:1284. 10.3390/biom11091284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Fleming AM, Burrows CJ. Oxidative stress-mediated epigenetic regulation by G-quadruplexes. NAR Cancer. 2021;3:zcab038. 10.1093/narcan/zcab038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Spencer DM, Svenungsson E, Gunnarsson I et al. The expression of antibodies to Z-DNA in the blood of patients with systemic lupus erythematosus: relationship to autoantibodies to B-DNA. Clin Immunol. 2023;255:109763. 10.1016/j.clim.2023.109763. [DOI] [PubMed] [Google Scholar]
- 103. Pisetsky DS, Gedye MJ, David LA et al. The binding properties of antibodies to Z-DNA in the sera of normal healthy subjects. Int J Mol Sci. 2024;25:2556. 10.3390/ijms25052556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104. Thanabalasuriar A, Scott BNV, Peiseler M et al. Neutrophil extracellular traps confine Pseudomonas aeruginosa ocular biofilms and restrict brain invasion. Cell Host Microbe. 2019;25:526–36. 10.1016/j.chom.2019.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Hendricks AL, More KR, Devaraj A et al. Bacterial biofilm-derived H-NS protein acts as a defense against neutrophil extracellular traps (NETs). npj Biofilms Microbiomes. 2025;11:58. 10.1038/s41522-025-00691-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Shafirovich V, Geacintov NE. Excision of oxidatively generated guanine lesions by competitive DNA repair pathways. Int J Mol Sci. 2021;22:2698. 10.3390/ijms22052698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. Visnes T, Cázares-Körner A, Hao W et al. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation. Science. 2018;362:834–9. 10.1126/science.aar8048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108. Azzouz D, Palaniyar N. ROS and DNA repair in spontaneous versus agonist-induced NETosis: context matters. Front Immunol. 2022;13:1033815. 10.3389/fimmu.2022.1033815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109. Liu H, Mulholland N, Fu H et al. Cooperative activity of BRG1 and Z-DNA formation in chromatin remodeling. Mol Cell Biol. 2006;26:2550–9. 10.1128/MCB.26.7.2550-2559.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110. Neubert E, Meyer D, Rocca F et al. Chromatin swelling drives neutrophil extracellular trap release. Nat Commun. 2018;9:3767. 10.1038/s41467-018-06263-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Habbane M, Montoya J, Rhouda T et al. Human mitochondrial DNA: particularities and diseases. Biomedicines. 2021;9:1364. 10.3390/biomedicines9101364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Hong EE, Okitsu CY, Smith AD et al. Regionally specific and genome-wide analyses conclusively demonstrate the absence of CpG methylation in human mitochondrial DNA. Mol Cell Biol. 2013;33:2683–90. 10.1128/MCB.00220-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Szczesny B, Marcatti M, Ahmad A et al. Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells. Sci Rep. 2018;8:914. 10.1038/s41598-018-19216-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. Lei Y, VanPortfliet JJ, Chen Y-F et al. Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity. Cell. 2023;186:3013–32. 10.1016/j.cell.2023.05.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115. Tamkovich SN, Cherepanova AV, Kolesnikova EV et al. Circulating DNA and DNase activity in human blood. Ann NY Acad Sci. 2006;1075:191–6. 10.1196/annals.1368.026. [DOI] [PubMed] [Google Scholar]
- 116. Krall JB, Nichols PJ, Henen MA et al. Structure and formation of Z-DNA and Z-RNA. Molecules. 2023;28:843. 10.3390/molecules28020843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117. Brooks WH. Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases. Front Immunol. 2013;4:91. 10.3389/fimmu.2013.00091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118. Wigerblad G, Kaplan MJ. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat Rev Immunol. 2023;23:274–88. 10.1038/s41577-022-00787-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119. Demkow U. Molecular mechanisms of neutrophil extracellular trap (NETs) degradation. Int J Mol Sci. 2023;24:4896. 10.3390/ijms24054896 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120. Kong L-Z, Kim S-M, Wang C et al. Understanding nucleic acid sensing and its therapeutic applications. Exp Mol Med. 2023;55:2320–31. 10.1038/s12276-023-01118-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121. Yang Y, Ren C, Xu X et al. Decoding the connection between SLE and DNA sensors: a comprehensive review. Int Immunopharmacol. 2024;137:112446. 10.1016/j.intimp.2024.112446. [DOI] [PubMed] [Google Scholar]
- 122. Kondo T, Okawa H, Hokugo A et al. Oral microbial extracellular DNA initiates periodontitis through gingival degradation by fibroblast-derived cathepsin K in mice. Commun Biol. 2022;5:962. 10.1038/s42003-022-03896-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123. Deng W, Lei Y, Tang X et al. DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models. Front Cell Infect Microbiol. 2022;12:917038. 10.3389/fcimb.2022.917038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124. Kou M, Wang L. Surface toll-like receptor 9 on immune cells and its immunomodulatory effect. Front Immunol. 2023;14:1259989. 10.3389/fimmu.2023.1259989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125. Lindau D, Mussard J, Wagner BJ et al. Primary blood neutrophils express a functional cell surface toll-like receptor 9: innate immunity. Eur J Immunol. 2013;43:2101–13. 10.1002/eji.201142143. [DOI] [PubMed] [Google Scholar]
- 126. Malfoy B, Leng M. Antiserum to Z-DNA. FEBS Lett. 1981;132:45–8. 10.1016/0014-5793(81)80424-3. [DOI] [PubMed] [Google Scholar]
- 127. Karki R, Lee S, Mall R et al. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection. Sci Immunol. 2022;7:eabo6294. 10.1126/sciimmunol.abo6294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128. Banoth B, Tuladhar S, Karki R et al. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020;295:18276–83. 10.1074/jbc.RA120.015924. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129. Tu ATT, Hoshi K, Ma Y et al. Effects of G-quadruplex ligands on the topology, stability, and immunostimulatory properties of G-quadruplex-based CpG oligodeoxynucleotides. ACS Chem Biol. 2022;17:1703–13. 10.1021/acschembio.1c00904. [DOI] [PubMed] [Google Scholar]
- 130. Kwakye-Berko F, Meshnick S. Sequence preference of chloroquine binding to DNA and prevention of Z-DNA formation. Mol Biochem Parasitol. 1990;39:275–8. 10.1016/0166-6851(90)90066-U. [DOI] [PubMed] [Google Scholar]
- 131. Wan M-C, Jiao K, Zhu Y-N et al. Bacteria-mediated resistance of neutrophil extracellular traps to enzymatic degradation drives the formation of dental calculi. Nat Biomed Eng. 2024;8:1177–90. 10.1038/s41551-024-01186-7. [DOI] [PubMed] [Google Scholar]
- 132. Wang H, Kim SJ, Lei Y et al. Neutrophil extracellular traps in homeostasis and disease. Sig Transduct Target Ther. 2024;9:235. 10.1038/s41392-024-01933-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133. Marcos V, Zhou-Suckow Z, Önder Yildirim A et al. Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm. 2015;2015:408935. 10.1155/2015/408935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134. Klein B, Reynolds MB, Xu B et al. Epidermal ZBP1 stabilizes mitochondrial Z-DNA to drive UV-induced IFN signaling in autoimmune photosensitivity. Sci Immunol. 2025;10:eado1710. 10.1126/sciimmunol.ado1710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135. Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol. 2013;191:2647–56. 10.4049/jimmunol.1300436. [DOI] [PubMed] [Google Scholar]
- 136. McCord JJ, Engavale M, Masoumzadeh E et al. Structural features of Dnase1L3 responsible for serum antigen clearance. Commun Biol. 2022;5:825. 10.1038/s42003-022-03755-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Suck D. DNA recognition by DNase I. J of Molecular Recognition. 1994;7:65–70. 10.1002/jmr.300070203. [DOI] [PubMed] [Google Scholar]
- 138. Hoshi K, Yamazaki T, Sugiyama Y et al. G-quadruplex structure improves the immunostimulatory effects of CpG oligonucleotides. Nucleic Acid Ther. 2019;29:224–9. 10.1089/nat.2018.0761. [DOI] [PubMed] [Google Scholar]
- 139. Means TK, Latz E, Hayashi F et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005;115:407–17. 10.1172/JCI23025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140. Kessenbrock K, Krumbholz M, Schönermarck U et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15:623–5. 10.1038/nm.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141. Gupta S, Kaplan MJ. The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol. 2016;12:402–13. 10.1038/nrneph.2016.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142. Ryan BJ, Nissim A, Winyard PG. Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol. 2014;2:715–24. 10.1016/j.redox.2014.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143. Gestermann N, Di Domizio J, Lande R et al. Netting neutrophils activate autoreactive B cells in lupus. J Immunol. 2018;200:3364–71. 10.4049/jimmunol.1700778. [DOI] [PubMed] [Google Scholar]
- 144. Lande R, Ganguly D, Facchinetti V et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011;3:73ra19. 10.1126/scitranslmed.3001180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145. Lood C, Blanco LP, Purmalek MM et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146–53. 10.1038/nm.4027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146. Villanueva E, Yalavarthi S, Berthier CC et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187:538–52. 10.4049/jimmunol.1100450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147. Hakkim A, Fürnrohr BG, Amann K et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA. 2010;107:9813–8. 10.1073/pnas.0909927107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148. Huang Y, Yang D-D, Li X-Y et al. ZBP1 is a significant pyroptosis regulator for systemic lupus erythematosus. Ann Transl Med. 2021;9:1773. 10.21037/atm-21-6193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149. Pisetsky DS, Herbert A. The role of DNA in the pathogenesis of SLE: DNA as a molecular chameleon. Ann Rheum Dis. 2024;83:1–8. 10.1136/ard-2023-225266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150. Noubouossie DF, Reeves BN, Strahl BD et al. Neutrophils: back in the thrombosis spotlight. Blood. 2019;133:2186–97. 10.1182/blood-2018-10-862243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151. Zhou Y, Xu Z, Liu Z. Impact of neutrophil extracellular traps on thrombosis formation: new findings and future perspective. Front Cell Infect Microbiol. 2022;12:910908. 10.3389/fcimb.2022.910908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152. Saravanan R, Choong YK, Lim CH et al. Cell-free DNA promotes thrombin autolysis and generation of thrombin-derived C-terminal fragments. Front Immunol. 2021;12:593020. 10.3389/fimmu.2021.593020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153. Lim CH, Adav SS, Sze SK et al. Thrombin and plasmin alter the proteome of neutrophil extracellular traps. Front Immunol. 2018;9:1554. 10.3389/fimmu.2018.01554. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Derszniak K, Przyborowski K, Matyjaszczyk K et al. Comparison of effects of anti-thrombin aptamers HD1 and HD22 on aggregation of human platelets, thrombin generation, fibrin formation, and thrombus formation under flow conditions. Front Pharmacol. 2019;10:68. 10.3389/fphar.2019.00068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155. Tasset DM, Kubik MF, Steiner W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol. 1997;272:688–98. 10.1006/jmbi.1997.1275. [DOI] [PubMed] [Google Scholar]
- 156. Li Y, Su L, Zhang Y et al. A guanosine-quadruplex hydrogel as cascade reaction container consuming endogenous glucose for infected wound treatment—a study in diabetic mice. Adv Sci. 2022;9:e2103485. 10.1002/advs.202103485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157. Fenati RA, Locock K, Qu Y et al. Oxacillin coupled G-quadruplexes as a novel biofilm-specific antibiotic for Staphylococcus aureus biofilms. ACS Appl Bio Mater. 2019;2:3002–8. 10.1021/acsabm.9b00336. [DOI] [PubMed] [Google Scholar]
- 158. Wang Z-G, Li Y, Wang H et al. Enzyme mimic based on a self-assembled Chitosan/DNA hybrid exhibits superior activity and tolerance. Chemistry A European J. 2019;25:12576–82. 10.1002/chem.201902509. [DOI] [PubMed] [Google Scholar]
- 159. Mitteaux J, Lejault P, Wojciechowski F et al. Identifying G-quadruplex-DNA-disrupting small molecules. J Am Chem Soc. 2021;143:12567–77. 10.1021/jacs.1c04426. [DOI] [PubMed] [Google Scholar]
- 160. Cavallari M, Garbesi A, Di Felice R. Porphyrin intercalation in G4-DNA quadruplexes by molecular dynamics simulations. J Phys Chem B. 2009;113:13152–60. 10.1021/jp9039226. [DOI] [PubMed] [Google Scholar]
- 161. Dutikova YV, Borisova OF, Shchyolkina AK et al. 5, 10, 15, 20-Tetra-(N-methyl-3-pyridyl)porphyrin destabilizes the antiparallel telomeric quadruplex d(TTAGGG)4. Mol Biol. 2010;44:823–31. 10.1134/S0026893310050201. [DOI] [PubMed] [Google Scholar]
- 162. Siddiqui-Jain A, Grand CL, Bearss DJ et al. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA. 2002;99:11593–8. 10.1073/pnas.182256799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163. Fracchioni G, Vailati S, Grazioli M et al. Structural unfolding of G-quadruplexes: from small molecules to antisense strategies. Molecules. 2024;29:3488. 10.3390/molecules29153488. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164. Fry M, Loeb LA. Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n. J Biol Chem. 1999;274:12797–802. 10.1074/jbc.274.18.12797. [DOI] [PubMed] [Google Scholar]
- 165. Wu Y, Shin-ya K, Brosh RM Jr. FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol. 2008;28:4116–28. 10.1128/MCB.02210-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166. Wu X, Maizels N. Substrate-specific inhibition of RecQ helicase. Nucleic Acids Res. 2001;29:1765–71. 10.1093/nar/29.8.1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167. Tippana R, Chen MC, Demeshkina NA et al. RNA G-quadruplex is resolved by repetitive and ATP-dependent mechanism of DHX36. Nat Commun. 2019;10:1855. 10.1038/s41467-019-09802-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168. Dörner T. Therapy: hydroxychloroquine in SLE: old drug, new perspectives: therapy. Nat Rev Rheumatol. 2010;6:10–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169. Goodman SD, Bakaletz LO. Bacterial biofilms utilize an underlying extracellular DNA matrix structure that can be targeted for biofilm resolution. Microorganisms. 2022;10:466. 10.3390/microorganisms10020466 . [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170. Macmaster R, Sedelnikova S, Baker PJ et al. RusA Holliday junction resolvase: DNA complex structure–insights into selectivity and specificity. Nucleic Acids Res. 2006;34:5577–84. 10.1093/nar/gkl447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171. Rogers JV, Hall VL, McOsker CC. Crumbling the castle: targeting DNABII proteins for collapsing bacterial biofilms as a therapeutic approach to treat disease and combat antimicrobial resistance. Antibiotics. 2022;11:104. 10.3390/antibiotics11010104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172. Conway J, Delanois RE, Mont MA et al. Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip. Antimicrob Agents Chemother. 2024;68:e0065524. 10.1128/aac.00655-24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 173. Hastings R, Ding T, Butt S et al. Neutropenia in patients receiving anti-tumor necrosis factor therapy. Arthritis Care & Research. 2010;62:764–9. 10.1002/acr.20037. [DOI] [PubMed] [Google Scholar]
- 174. Ali T, Kaitha S, Mahmood S et al. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 2013;5:79–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175. Kim YG, Kim PS, Herbert A et al. Construction of a Z-DNA-specific restriction endonuclease. Proc Natl Acad Sci USA. 1997;94:12875–9. 10.1073/pnas.94.24.12875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176. Dang DT, Nguyen LTA, Truong TTT et al. Construction of a G-quadruplex-specific DNA endonuclease. Chem Commun. 2021;57:4568–71. 10.1039/D0CC05890D. [DOI] [PubMed] [Google Scholar]
- 177. Wittig B, Dorbic T, Rich A. Transcription is associated with Z-DNA formation in metabolically active permeabilized mammalian cell nuclei. Proc Natl Acad Sci USA. 1991;88:2259–63. 10.1073/pnas.88.6.2259. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No new data were generated or analysed in support of this research.


